Literature DB >> 11062788

Screening for abdominal aortic aneurysm: lessons from a population-based study.

K Jamrozik1, P E Norman, C A Spencer, R W Parsons, R Tuohy, M M Lawrence-Brown, J A Dickinson.   

Abstract

OBJECTIVES: To test the acceptability of screening and to identify modifiable risk factors for abdominal aortic aneurysm (AAA) in men.
DESIGN: A trial of ultrasound screening for AAA in a population-based random sample of men aged 65-83 years, and a cross-sectional case-control comparison of men in the same sample. PARTICIPANTS: 12,203 men who had an ultrasound examination of their abdominal aorta, and completed a questionnaire covering demographic, behavioural and medical factors. MAIN OUTCOME MEASURES: Prevalence of AAA, and independent associations of AAA with demographic, medical and lifestyle factors.
RESULTS: Invitations to screening produced a corrected response of 70.5%. The prevalence of AAAs (> 30 mm) rose from 4.8% in men aged 65-69 years to 10.8% in those aged 80-83 years. The overall prevalence of large (> 50 mm) aneurysms was 0.69%. In a multivariate logistic model Mediterranean-born men had a 40% lower risk of AAA (> 30 mm) compared with men born in Australia (odds ratio [OR], 0.6; 95% CI, 0.4-0.8), while ex-smokers had a significantly increased risk of AAA (OR, 2.3; 95% CI, 1.9-2.8), and current smokers had even higher risks. AAA was significantly associated with established coronary and peripheral arterial disease and a waist:hip ratio greater than 0.9; men who regularly undertook vigorous exercise had a lower risk (OR, 0.8; 95% CI, 0.7-1.0).
CONCLUSION: Ultrasound screening for AAA is acceptable to men in the likely target population. AAA shares some but not all of the risk factors for occlusive vascular disease, but the scope for primary prevention of AAA in later life is limited.

Entities:  

Mesh:

Year:  2000        PMID: 11062788     DOI: 10.5694/j.1326-5377.2000.tb125684.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  27 in total

1.  Screening for abdominal aortic aneurysms in men.

Authors:  J J Earnshaw; E Shaw; M R Whyman; K R Poskitt; B P Heather
Journal:  BMJ       Date:  2004-05-08

2.  Vascular ultrasound screening for asymptomatic abdominal aortic aneurysm.

Authors:  Joanne Thanos; Mayvis Rebeira; B William Shragge; David Urbach
Journal:  Healthc Policy       Date:  2008-11

Review 3.  Everyday Impact of Cognitive Interventions in Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.

Authors:  M J Chandler; A C Parks; M Marsiske; L J Rotblatt; G E Smith
Journal:  Neuropsychol Rev       Date:  2016-09-08       Impact factor: 7.444

4.  Abdominal aortic aneurysm (AAA): cost-effectiveness of screening, surveillance of intermediate-sized AAA, and management of symptomatic AAA.

Authors:  Marc D Silverstein; Stephen R Pitts; Elliot L Chaikof; David J Ballard
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-10

5.  Relationship between two sequence variations in the gene for peroxisome proliferator-activated receptor-gamma and plasma homocysteine concentration. Health in men study.

Authors:  Jonathan Golledge; Paul E Norman
Journal:  Hum Genet       Date:  2007-11-13       Impact factor: 4.132

6.  Ultrasound screening for abdominal aortic aneurysm: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-01-01

7.  Polymorphisms of the matrix metalloproteinase 9 gene and abdominal aortic aneurysm.

Authors:  L Smallwood; R Allcock; F van Bockxmeer; N Warrington; L J Palmer; B Iacopetta; J Golledge; P E Norman
Journal:  Br J Surg       Date:  2008-10       Impact factor: 6.939

Review 8.  Understanding the effects of tobacco smoke on the pathogenesis of aortic aneurysm.

Authors:  Paul E Norman; John A Curci
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-16       Impact factor: 8.311

9.  The development of abdominal aortic aneurysms in mice is enhanced by benzo(a)pyrene.

Authors:  Yong Zhang; Kenneth S Ramos
Journal:  Vasc Health Risk Manag       Date:  2008

10.  The PACE study: a randomised clinical trial of cognitive activity (CA) for older adults with mild cognitive impairment (MCI).

Authors:  Mandy R Vidovich; Nicola T Lautenschlager; Leon Flicker; Linda Clare; Osvaldo P Almeida
Journal:  Trials       Date:  2009-12-14       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.